Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you reach the last dose in your current Mounjaro pen and a new one is waiting in the fridge, the question is simple: can you just pick up where you left off? In most cases, yes. Each Mounjaro KwikPen contains four weekly doses, and moving to a fresh pen of the same strength on your usual injection day is straightforward. The decision only becomes more complicated if your new pen is a different strength, if your schedule has shifted, or if you are switching after a missed dose. Mounjaro is a prescription-only medicine, so any changes to your dose or titration schedule should be guided by your prescriber, not worked out alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common pen change is simply finishing one KwikPen and starting another at the same strength. There is no adjustment needed here. You inject on your usual day, from a new pen, and your body does not register the difference. The NHS patient information on tirzepatide confirms that each pen is pre-filled and disposed of after its four weekly injections are complete.
What catches people out is the practicality: the pen lives in the fridge, and a new one must be stored the same way until first use. Once you start the new pen, check that it looks right before injecting, the solution should be clear and colourless. If it appears cloudy or discoloured, do not use it. Contact your pharmacy.
If you are ever unsure whether a pen has been used, the dose counter on the KwikPen shows how many doses remain. Full detail on reading the counter and priming the pen is in the Patient Information Leaflet that comes with every box, the NHS tirzepatide medicines page also summarises the practical steps. You can find broader technique guidance on the Mounjaro injection page if you want a walk-through of the full process.
Titrating up (going from, say, 5mg to 7.5mg) is where people most often feel unsure. The pen changes, the dose changes, and the question of when to make the switch matters. The licensed schedule steps up in 4-week increments, starting at the 2.5mg starter pen, but your prescriber sets the pace based on how you have tolerated each stage. A clinical review should happen before you move to a new strength; that is not a formality, it is what the process exists for.
At nume, a prescriber personally reviews your case before a higher-dose pen is approved and dispatched. Side effects tend to be most noticeable when the dose increases, nausea, changes in digestion and fatigue are common in the days following a step-up. These usually settle. The Mounjaro pen guide covers what the different strengths look like and how the KwikPen works across the titration schedule.
One practical note: if you have been on a dose for longer than four weeks due to tolerability, that is not a problem, staying at a lower strength for an extra cycle is often the right call. Talk to your prescriber about your specific timeline rather than switching pens because you feel you should be moving faster.
Starting a new pen is sometimes used as a natural point to shift your injection day, perhaps from a Friday to a Tuesday because your schedule has changed. This is possible, but the rule is that consecutive injections must be at least three days apart, so if you last injected on a Friday, you cannot restart on a Monday; Tuesday at the earliest is safe, and understanding exactly how to change your injection day on Mounjaro will help you plan the timing correctly.
More on the specifics of rescheduling is covered on the page about changing your Mounjaro injection day, including what to do if you want to move the day earlier rather than later. The clinical considerations around changing injection day are also worth reading before you adjust anything.
If you have moved house, changed routine or are planning travel, rotating your injection site on the body is also worth revisiting, abdomen, thigh and upper arm are all licensed sites, and varying them reduces the chance of localised reactions.
A pen change is also the right moment to check the practical habits that matter for safety. Every injection requires a new needle, needles are single use, full stop. Reusing a needle increases the risk of infection, inaccurate dosing and injection-site reactions. A separate box of replacement needles means you will never find yourself reusing one because you have run out.
Used pens and needles go into a sharps bin, not the household bin or a recycling box. A 1-litre sharps container is the standard choice for most patients on weekly injections; your local council or pharmacy will confirm the local collection scheme.
The wider question of cost (whether switching providers, adjusting doses or exploring what a private prescription includes) is addressed on our weight-loss treatments page. If you have questions about how our clinical review works, the clinical team profile gives detail on the prescribers behind every consultation at nume. And for anything not covered here, the FAQs are a good next stop.
For most people, a pen change is uneventful. The clinical part (when to step up, what to do after a missed dose, whether a change in manufacturer batch should concern you) is exactly what a prescriber is there for. If you are starting treatment from scratch, a free consultation is the right place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.